These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7217961)
41. [Effectiveness of tolfenamic acid in the prevention of migraine]. Vaitkus A; Pauza V Medicina (Kaunas); 2002; 38(3):296-303. PubMed ID: 12474702 [TBL] [Abstract][Full Text] [Related]
44. Sandomigran in the treatment of migrainous patients. Bánki CM; Vigváry L Ther Hung; 1981; 29(4):181-5. PubMed ID: 7188144 [No Abstract] [Full Text] [Related]
45. A retrospective study to assess the migraine headache remission rate after cessation of pizotifen therapy. Capildeo R; Wimalaratna HS; Bosley E; Shah SN Br J Clin Pract; 1990 Dec; 44(12):622-6. PubMed ID: 2102160 [No Abstract] [Full Text] [Related]
46. Sanomigran for migraine prophylaxis, controlled multicenter trial in general practice. Lawrence ER; Hossain M; Littlestone W Headache; 1977 Jul; 17(3):109-12. PubMed ID: 330465 [No Abstract] [Full Text] [Related]
47. Biochemical pharmacological profile of migraine prophylactics of pizotifen type. Dlohozková N; Metys J; Valchár M; Soucek R Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122 [No Abstract] [Full Text] [Related]
48. Single-dose pizotifen, 1.5 mg nocte: a new approach in the prophylaxis of migraine. Capildeo R; Rose FC Headache; 1982 Nov; 22(6):272-5. PubMed ID: 7174305 [No Abstract] [Full Text] [Related]
50. [Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)]. Bousser MG; Conard J; Lecrubier C; Bousser J Ann Med Interne (Paris); 1980; 131(2):87-90. PubMed ID: 7396326 [TBL] [Abstract][Full Text] [Related]
51. [Platelet aggregation in patients with migraine during the pain attack and in the pain-free period]. Kozubski W; Stańczyk L Neurol Neurochir Pol; 1985; 19(4):302-7. PubMed ID: 4094642 [TBL] [Abstract][Full Text] [Related]
52. [Headache in childhood: diagnosis and therapy. A prospective study of 77 cases]. Muszkat M; Vergani MI; Torres DM Arq Neuropsiquiatr; 1988 Sep; 46(3):254-7. PubMed ID: 3265615 [TBL] [Abstract][Full Text] [Related]
54. Migraine: a platelet disorder. Hanington E; Jones RJ; Amess JA; Wachowicz B Lancet; 1981 Oct; 2(8249):720-3. PubMed ID: 6116859 [TBL] [Abstract][Full Text] [Related]
55. [Platelet aggregation in migraine and other headaches]. Judkiewicz L; Klimek A; Niewiarowska J; Ciszewski R; Głuszcz-Zielińska A Neurol Neurochir Pol; 1984; 18(6):529-33. PubMed ID: 6536861 [TBL] [Abstract][Full Text] [Related]
56. Platelet aggregation in migraine. Jha S; Varma M; Garg R; Kar AM J Assoc Physicians India; 1992 Mar; 40(3):153-4. PubMed ID: 1634476 [TBL] [Abstract][Full Text] [Related]
57. Drugs and platelet activation in migraine and transient ischemic attacks. D'Andrea G; Canazi A; Toldo M; Ferro-Milone F Cephalalgia; 1985 May; 5 Suppl 2():103-8. PubMed ID: 3160472 [TBL] [Abstract][Full Text] [Related]
58. Long-term effect of pizotifen treatment on growth hormone levels of underweight children, including those with anorexia nervosa. Dolecek R; Janstová V Pharmatherapeutica; 1985; 4(2):81-7. PubMed ID: 4059293 [TBL] [Abstract][Full Text] [Related]
59. Do pizotifen or propranolol reduce the frequency of migraine headache? Barnes N; Millman G Arch Dis Child; 2004 Jul; 89(7):684-5. PubMed ID: 15210509 [No Abstract] [Full Text] [Related]
60. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study. Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]